Resources

Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.

 

Hospital Buprenorphine Program for Opioid Use Disorder Is Associated With Increased Inpatient and Outpatient Addiction Treatment

This study reports the outcomes of the B-Team (Buprenorphine-Team), a hospitalist-led interprofessional program created to identify hospitalized patients with OUD, initiate buprenorphine in the inpati
Original research | 2021
Clinical guidance, Evidence base, Wrap-around services, About prescribers, Outcomes, Substitution/OAT, Transitions in care/treatment, Hospitals

Injection drug use cessation and use of North America's first medically supervised safer injecting facility

Assess whether Insite facilitated drug use and/or delayed entry into drug treatment
Original research | 2010
Illegal drugs, Indigenous, Transitions in care/treatment, SCS/OPS

Pharmacokinetics of Fentanyl Buccal Tablet: A Pooled Analysis and Review

This analysis provides an overview of the pharmacokinetic profile of FBT based on pooled data from nine pharmacokinetic studies.
Original research | 2012
About prescribers, Chronic pain

Putting the Horse Before the Unicorn: A Safe Supply Strategy Should Begin With Partial Agonists—A Commentary on Bonn et al. (2020).

Response to Bonn et al

Commentary | 2020
Policy/Regulatory, Safer supply, Advocacy

Reports of accidental fentanyl overdose among police in the field: Toward correcting a harmful culture-bound syndrome

Commentary | 2022
Overdose, Advocacy, Legal system/law enforcement, Illegal drugs, Stigma, Mental health

Safe Supply: Hydromorphone Tablet Distribution Program at the Molson Overdose Prevention Site

Identify key barriers and facilitators to participant engagement with the hydromorphone tablet program.

Original research | 2020
Safer supply, Barriers and enablers, Injecting drugs

Socioeconomic correlates of incident and fatal opioid overdose among Swedish people with opioid use disorder

Socioeconomic factors are underexplored potential determinants of opioid OD.
Original research | 2021
Overdose, Policy/Regulatory, Equity, Social services, Outcomes, Poverty, Legal system/law enforcement

The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis

Look at drivers of the US opioid crisis
Commentary | 2019
Mortality, Policy/Regulatory, Illegal drugs, Drug checking, SCS/OPS

The Work of "Crisis" in the "Opioid Crisis"

Commentary | 2018
Overdose, Advocacy

Would legalizing illicit opioids reduce overdose fatalities? Implications from a natural experiment

Examines whether the provision of regulated and quality-controlled heroin to users in specified doses would reduce heroin overdose rates
Commentary | 2014
Overdose, Policy/Regulatory, Safer supply

"The Times They Are a-Changin'": Addressing Common Misconceptions About the Role of Safe Supply in North America's Overdose Crisis

Response to responses on Bonn et al "Addressing the Syndemic…"

Letter | 2021
Policy/Regulatory, Safer supply, Advocacy, Illegal drugs

A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia

To examine characteristics of first-time methadone and buprenorphine clients and factors associated with risk of leaving first treatment in New South Wales (NSW), Australia.
Original research | 2015
Harm reduction, About prescribers, Outcomes, Crime, Legal system/law enforcement, Substitution/OAT

Addressing the Syndemic of HIV, Hepatitis C, Overdose, and COVID-19 Among People Who Use Drugs: The Potential Roles for Decriminalization and Safe Supply

Commentary | 2020
Safer supply, Decriminalization/legalization, Advocacy, Housing

Assessment tools measuring health-related empowerment in psychosocially vulnerable populations: a systematic review

This systematic review aims to describe and summarise psychometric properties, feasibility and clinical utility of the available tools for measuring empowerment in psychosocially vulnerable population
Lit review | 2021
Equity, Peer/PWLLE program involvement, Social benefits

Canadian Pain Task Force Report: March 2021

Report | 2021
Overdose, Harm reduction, Policy/Regulatory, Equity, Advocacy, About prescribers, About PWUD, Legal system/law enforcement, Illegal drugs, Youth, Chronic pain, Workplace, 2SLGBTQI+, Indigenous, Sex/Gender , Mental health

Caring for hospital patients who inject drugs

Slide deck | 2019
Clinical guidance, Harm reduction, About prescribers, Illegal drugs, Hospitals

Caring for people who inject drugs when they are admitted to hospital

Commentary | 2021
Withdrawal, Clinical guidance, Policy/Regulatory, About prescribers, Illegal drugs, Stigma, Hospitals

Decisions Around Prescribing Opioids for “Safe Supply”

Newsletter | 2019
Hesitancy of prescribers , Safer supply, About prescribers, Injecting drugs

Decriminalizing drug possession in Canada: Recent developments

Slide deck | 2021
Policy/Regulatory, Decriminalization/legalization, Advocacy, About PWUD

Expertise of people who use drugs must be central to design of safe supply

Commentary | 2020
Harm reduction, Policy/Regulatory, Safer supply, Decriminalization/legalization, Advocacy, About PWUD, Illegal drugs, Peer/PWLLE program involvement

Refine Your Search

Keywords
Format
Region